Correlation analyses based on their expression in cancer tissue and clinical outcome for cancer patients revealed that many (109/140, 78%) of the FUT8 targets had clinical prognostic values for breast cancer and also other cancer types: cervical, colorectal, endometrial, glioma, head and neck, lung, liver, ovarian, pancreatic, renal, stomach, thyroid, and urothelial cancers (Fig. 3a and Additional file 4: Table S2). This evidence concerns the gene FUT8 and glioma.